Free Submission Public Relations & NewsPR-inside.com
Home
Deutsch English

Health

Central America Pharmaceuticals & Healthcare Report Q3 2013 - New Market Report


Print article Print article
2013-05-20 23:53:13 - Fast Market Research recommends "Central America Pharmaceuticals & Healthcare Report Q3 2013" from Business Monitor International, now available

Commercial incentives for foreign drugmakers to expand in the Central American pharmaceutical market are limited by the region's relatively low per capita pharmaceutical spending and market growth. However, the heavy reliance on imported medicine in the region provides revenuegenerating opportunities for generic drugmakers from neighbouring Latin American countries and India. We believe that Costa Rica will continue to attract investment as a regional pharmaceutical production hub. We also highlight that Panama can be a premier country in the region for foreign drugmakers to expand their presence.

Full Report Details at
- www.fastmr.com/prod/596801_central_america_pharmaceuticals_healt ..

Headline Expenditure Projections

* Pharmaceuticals: US$3.4bn in 2012 to US$3.6bn in 2013; +5.5% in US dollar terms. Our forecast has been revised slightly downwards since Q213 due to new

historical data.
* Healthcare: US$15.0bn in 2012 to US$16.3bn in 2013; +8.5% in US dollar terms. Our forecast has been revised upwards since Q213 due to improved historical data.

Risk/Reward Ratings: In BMI's Q313 Pharmaceutical Risk/Reward Ratings (RRRs), we have re-weighted the RRR components to improve the tool, and adjusted scores for all markets in the Pharmaceuticals & Healthcare reports. Based on our analysis and assessment of the market's appeal to pharmaceutical companies, the Americas region continues to rank second-lowest globally with a score of 51.0 out of 100, compared to Western Europe (67.0), Central and Eastern Europe (52.0) Middle East and Africa (43.0) and Asia Pacific (54). Of the seven Central American countries surveyed, Panama's RRR score ranked top, followed by Costa Rica (40.8), Guatemala (38.8), Honduras (37.0), El Salvador (37.0), Belize (36.9) and Nicaragua (33.5)

Key Trends And Developments

* In March 2013, MicroVention, a subsidiary of Japanese medical device manufacturer Terumo Corporation, opened a new manufacturing facility in San Jose, Costa Rica. The new plant is MicroVention's first manufacturing facility outside the US and the first neurovascular manufacturing facility in Costa Rica. It is located at the Coyol Free Zone in the Alajuela region of Costa Rica. This new facility will support the growth and expansion of products offered under the MicroVention and Terumo brand.
* In February 2013, Sterigenics, a multinational sterilisation service provider to the medical device, pharmaceutical and food industries, invested US$9.5mn in San Jose, Costa Rica. The company has 40 service centres in 12 countries, although its only Latin American presence so far is two plants in Mexico.

BMI Economic View: Our expectations for a global rebalancing over the coming decade, with more sluggish US economic activity and rising competition from Asia, suggest that for much of the next decade, Central America will post fairly tepid growth. However, toward the end of our forecast period, we note that growth could begin to re-accelerate as the region benefits from more favourable demographic dynamics, rising investment into its transport and infrastructure sectors and greater demand for its manufactured exports from a rising Latin American middle class.

Partial Table of Contents:

BMI Industry View
SWOT
- SWOT
- SWOT : Political
- SWOT : Economic
Industry Forecast
- Pharmaceutical Market Forecast
- Table: Pharmaceutical Sales Indicators
- Guatemala
- Table: Guatemala Pharmaceutical Sales Forecasts
- Costa Rica
- Table: Costa Rica Pharmaceutical Sales Forecasts
- El Salvador
- Table: El Salvador Pharmaceutical Sales Forecasts
- Honduras
- Table: Honduras Pharmaceutical Sales Forecasts
- Panama
- Table: Panama Pharmaceutical Sales Forecasts
- Nicaragua
- Table: Nicaragua Pharmaceutical Sales Forecasts
- Belize
- Table: Belize Pharmaceutical Sales Forecasts
- Healthcare Forecast
- Guatemala
- Table: Guatemala Healthcare Expenditure Forecasts
- Costa Rica
- Table: Costa Rica Healthcare Expenditure Forecasts
- El Salvador
- Table: El Salvador Healthcare Expenditure Forecasts
- Panama
- Table: Panama Healthcare Expenditure Forecasts
- Honduras
- Table: Honduras Healthcare Expenditure Forecasts
- Nicaragua
- Table: Nicaragua Healthcare Expenditure Forecasts
- Belize
- Table: Belize Healthcare Expenditure Forecasts
- Pharmaceutical Trade Forecast
- Guatemala
- Table: Guatemala Pharmaceutical Trade Data And Forecasts (US$mn)
- Costa Rica
- Table: Costa Rica Pharmaceutical Trade Data And Forecasts (US$mn)
- El Salvador
- Table: El Salvador Pharmaceutical Trade Data And Forecasts (US$mn)
- Panama
- Table: Panama Pharmaceutical Trade Data And Forecasts (US$mn)
- Honduras
- Table: Honduras Pharmaceutical Trade Data And Forecasts (US$mn)
- Nicaragua
- Table: Nicaragua Pharmaceutical Trade Data And Forecasts (US$mn)
- Belize
Industry Risk Reward Ratings
- Americas Risk/Reward Ratings
- Central America Industry Risk/Reward Ratings
Industry Trends And Developments
- Regional Developments
- Guatemala
- Costa Rica
- El Salvador
- Panama
- Honduras
- Nicaragua
- Belize
- Epidemiology
- Clinical Trials
Regulatory Development
- Regulatory Regime
- Intellectual Property Regime
- Costa Rica
- El Salvador
- Honduras
- Nicaragua
- Panama
- Guatemala
Competitive Landscape
Company Profile

Full Table of Contents is available at:
-- www.fastmr.com/catalog/product.aspx?productid=596801&dt=t

About Business Monitor International

Business Monitor International (BMI) offers a comprehensive range of products and services designed to help senior executives, analysts and researchers assess and better manage operating risks, and exploit business opportunities, across 175 markets. BMI offers three main areas of expertise: Country Risk BMI's country risk and macroeconomic forecast portfolio includes weekly financial market reports, monthly regional Monitors, and in-depth quarterly Business Forecast Reports. Industry Analysis BMI covers a total of 17 industry verticals through a portfolio of services, including in-depth quarterly Country Forecast Reports. View more research from Business Monitor International at www.fastmr.com/catalog/publishers.aspx?pubid=1010

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at www.fastmr.com or call us at 1.800.844.8156.


Author:
Bill Thompson
e-mail
Web: www.fastmr.com
Phone: 18008448156

Disclaimer: If you have any questions regarding information in these press releases please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims contents contained in this release.
Latest News
Read the Latest News
www.newsenvoy.com

 


Terms & Conditions | Privacy | About us | Contact PR-inside.com